Organic Active Ingredients TRIZ Cases

Adding lixisenatide to existing insulin glargine and metformin regimens resolves inadequate glycemic control by improving HbA1c levels.

Formic acid mediates solubility of basic drugs in volatile solvents, enabling stable amorphous solid dispersions at modest temperatures.

Arylene compounds inhibit p38 MAPK activity via inhalation, resolving the trade-off between therapeutic duration and pulmonary deliverability.

Extracting phorbol intermediates from Croton tiglium seeds overcomes geographical supply constraints for scalable tigilanol tiglate production.

Allosteric binding overcomes orthosteric conservation limits, enabling selective mGlu2 modulation for neurological disorders.

Novel N-substituted ferroportin inhibitors block iron transport to prevent tissue overload while reducing toxicity associated with chelation therapies.

A faecal mimic composition restores functional faeces production in patients with temporary derivative ileostomy.

Ion exchange resin-bound phenylephrine prevents premature release and interaction issues in modified release analgesic suspensions.

Substituted 4-fluoro-2,5-dihydrofuranyl phosphonic acid inhibits LINE1 and HERV-K reverse transcriptases to treat medical disorders.

6-ETI nucleoside analogs exploit elevated adenosine kinase activity to selectively destroy tumor cells while sparing normal tissue.

Combining CpG-oligodeoxynucleotides with immune checkpoint inhibitors activates TLR9 receptors to stimulate anti-tumor immunity.

Penetration enhancers facilitate drug transport through the stratum corneum barrier, resolving hydrophobic solubility limits.

Aziridinyl dimeric naphthoquinones overcome drug resistance by combining oxidative stress induction with direct DNA alkylation to inhibit cell proliferation.

Chemically modified siRNA molecules down-regulate KRAS mRNA to overcome acquired resistance in refractory cancers.

Co-administering cytokine signaling immunomodulators with antigen-carrier conjugates boosts germinal center formation and IgG2a/IgG3 antibody concentrations.

Optimized oral liquid chlorpromazine formulation maintains stability and reduces impurity generation for pediatric and geriatric patients.

Nanoclusters aggregate nanoparticles into controlled aerodynamic structures to resolve lung deposition and industrial handling contradictions.

Slow-dissolving soft lozenges deliver sustained topical corticosteroids to the esophagus, avoiding variable inhalation doses and systemic absorption risks.

Amino acid compositions mitigate radiation-induced gastrointestinal toxicity while maintaining cancer cell destruction efficacy.

Optimizing pharmaceutical stability and efficacy through selected polymorphs overcomes complex immune-suppressive pathways.

GPBP-1 inhibitors block kinase and chaperone activities to prevent insulin resistance in type 2 diabetes.

Quinoline carboxamide derivatives inhibit protein tyrosine kinases through targeted molecular design.

A CNS homing peptide conjugates psilocybin to target specific central nervous system regions, reducing non-specific distribution and side effects.

PROTAC compounds recruit E3 ligases to degrade RIP2 kinase, overcoming limited efficacy of traditional small molecule inhibitors.

L-Ergothioneine prevents age-related visual degeneration by activating endogenous antioxidant pathways and inhibiting oxidation-induced fibrosis.

Thapsigargin-treated tumor cells stimulate host immunity to destroy cancer while avoiding systemic toxicity.

Human milk oligosaccharides stimulate beneficial gut bacteria to reduce inflammation and improve bowel regularity in renal disease patients.

A benzyloxy pyridine derivative induces p62 protein oligomerization to activate selective autophagy.

A compound binds to heat shock protein 60 and inhibits ClpP interaction.

Oral dissolvable dosage form combines cranberry extract and vitamin C for gingivitis treatment.

Novel 5,6-fused bicyclic compounds inhibit kinetoplastid parasite growth via targeted proteasome interference.

Hexyldecanol counteracts glycerin's retarding effect on niacinamide, increasing skin layer recovery rates.

Substituted aromatic compounds target the HCV NS5A phosphoprotein to inhibit viral replication in drug-resistant strains.

Novel aromatic ring-fused lactam compounds inhibit ERK1/2 kinase activity at low concentrations.

A biomarker composition measuring AURKA and MYC gene expression levels predicts therapeutic response to anticancer drugs.

Rosemarinic acid complexes with elderberry anthocyanins to prevent degradation and boost oral bioavailability for pharmaceutical use.

Sugar alcohol crosslinkers enable site-specific conjugation of therapeutic agents through selective hydroxyl reactivity.

Ultra-high pressure dispersion produces pure hyaluronic acid nanoparticles without organic solvents, overcoming structural modification and low yield issues.

Covalently bonded chelators sequester cobalt and nickel ions to reduce metallosis toxicity without invasive implant removal surgery.

Novel isosorbide-based compounds release nitric oxide at the endothelial surface to induce localized vasodilation.

An aqueous ivermectin nano-suspension with Tween 80 stabilizes particles below 600 nm, enabling safe inhalation without organic solvent irritation.

Droplet solidification forms core-shell particles with small diameters, avoiding complex multi-step coating processes that increase size.

Pentameric, trimeric, and tetrameric procyanidins inhibit viral entry across genotypes, preventing re-infection after liver transplantation.

Solid dosage forms combine four antiviral compounds with stabilizing polymers to enhance bioavailability.

Disubstituted 5-fluoro pyrimidine derivatives with a sulfoximine group target the CDK9/Cyclin T1 kinase complex.

Sodium citrate, vitamin C, and L-lysine bind calcium ions in plaque to remove hard deposits without invasive surgery or harmful side effects.